Details for New Drug Application (NDA): 022076
✉ Email this page to a colleague
The generic ingredient in LOCOID is hydrocortisone butyrate. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
Summary for 022076
| Tradename: | LOCOID |
| Applicant: | Bausch |
| Ingredient: | hydrocortisone butyrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | LOTION;TOPICAL | Strength | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | May 18, 2007 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 022076
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | LOCOID | hydrocortisone butyrate | LOTION;TOPICAL | 022076-001 | May 18, 2007 | 7,981,877 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
